Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

BIO
Bio-Rad Laboratories, Inc.Class A
stock NYSE

At Close
Oct 17, 2025 3:59:56 PM EDT
310.04USD-0.714%(-2.23)131,200
0.00Bid   0.00Ask   0.00Spread
Pre-market
0.00USD-100.000%(-312.27)0
After-hours
Oct 17, 2025 4:34:30 PM EDT
313.00USD+0.955%(+2.96)100
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 25, 2022
08:00AM EST  Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022   Business Wire
Jan 24, 2022
09:47AM EST  Overview Of Value Stocks In The Healthcare Sector   Benzinga
Jan 5, 2022
04:15PM EST  Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11   Business Wire
Dec 16, 2021
08:05AM EST  Bio-Rad Appoints Simon May As EVP And Life Science Group President   RTTNews
08:00AM EST  Bio-Rad Appoints Simon May Executive Vice President and Life Science Group President   Business Wire
Dec 13, 2021
08:35AM EST  Albireo To Present Posters At NASPGHAN 2021 Dec. 13 And 15   Benzinga
Nov 1, 2021
10:55AM EDT  A Look Into Healthcare Sector Value Stocks   Benzinga
Oct 29, 2021
08:00AM EDT  The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs   Benzinga
Oct 28, 2021
04:45PM EDT  Bio-Rad Laboratories Q3 EPS $3.71 Beats $2.44 Estimate, Sales $747.00M Beat $661.87M Estimate   Benzinga
04:16PM EDT  Bio-Rad Reports Third-Quarter 2021 Financial Results   Business Wire
08:26AM EDT  The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug   Benzinga
04:08AM EDT  Earnings Scheduled For October 28, 2021   Benzinga
Oct 27, 2021
11:55AM EDT  Preview: Bio-Rad Laboratories's Earnings   Benzinga
Oct 25, 2021
11:20AM EDT  Overview Of Value Stocks In The Healthcare Sector   Benzinga
Oct 24, 2021
11:45AM EDT  The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More   Benzinga
Oct 15, 2021
08:00AM EDT  Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021   Business Wire
Oct 9, 2021
09:59AM EDT  15 Under 40, 14 Over 90: A Look At The Youngest And Oldest Members Of The Forbes 400 List   Benzinga
Sep 27, 2021
10:20AM EDT  5 Value Stocks To Watch In The Healthcare Sector   Benzinga
Sep 10, 2021
08:00AM EDT  The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test   Benzinga
Sep 8, 2021
07:32AM EDT  The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod   Benzinga
Sep 3, 2021
07:31AM EDT  The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself   Benzinga
Sep 2, 2021
08:20AM EDT  The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab   Benzinga
Sep 1, 2021
07:32AM EDT  The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering   Benzinga
Aug 31, 2021
08:15AM EDT  The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical   Benzinga
08:00AM EDT  Bio-Rad to Participate in the 2021 Virtual Wells Fargo Healthcare Conference   Business Wire
Aug 26, 2021
08:09AM EDT  The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO   Benzinga
Aug 25, 2021
07:30AM EDT  The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug   Benzinga
Aug 24, 2021
08:09AM EDT  The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal   Benzinga
Aug 19, 2021
10:57AM EDT  The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 13, 2021
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
Aug 6, 2021
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
Aug 5, 2021
08:08AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
Aug 4, 2021
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
Aug 3, 2021
07:55AM EDT  The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business   Benzinga
Jul 30, 2021
07:54AM EDT  The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs   Benzinga
07:30AM EDT  Wells Fargo Maintains Overweight on Bio-Rad Laboratories, Raises Price Target to $930   Benzinga
Jul 29, 2021
05:14PM EDT  Bio-Rad Laboratories Q2 EPS $3.54 Beats $2.66 Estimate, Sales $715.93M Beat $631.78M Estimate   Benzinga
04:48PM EDT  Recap: Bio-Rad Laboratories Q2 Earnings   Benzinga
04:15PM EDT  Bio-Rad Reports Second-Quarter 2021 Financial Results   Business Wire
08:18AM EDT  The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs   Benzinga
04:23AM EDT  Earnings Scheduled For July 29, 2021   Benzinga
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
Jul 27, 2021
12:28PM EDT  10x Genomics Entered Global Settlement And Patent Cross License With Bio-Rad Laboratories Resolving All Outstanding Litigation; Co. To Pay Bio-Rad $29.4M In Royalties And Interest Related To GEM Product Sales   Benzinga
12:27PM EDT  Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations   Business Wire
06:30AM EDT  Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes   GlobeNewswire Inc
Jul 25, 2021
10:05AM EDT  The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More   Benzinga
Jul 14, 2021
04:15PM EDT  Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021   Business Wire
Jul 8, 2021
07:45AM EDT  The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test   Benzinga
Jun 30, 2021
05:00PM EDT  Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products   Benzinga
Jun 21, 2021
08:56AM EDT  Bio-Rad Laboratories Inc. (BIO) said that it has launched its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit, a tool used to detect SARS-CoV-2 in a community's wastewater.   RTTNews
08:12AM EDT  Bio-Rad Launches PREvalence DdPCR SARS-CoV-2 Wastewater Quantification Kit   RTTNews
08:00AM EDT  Bio-Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing   Business Wire
Jun 14, 2021
09:57AM EDT  5 Value Stocks To Watch In The Healthcare Sector   Benzinga
Jun 2, 2021
07:44AM EDT  Royalty Pharma Announces $2.025B Funding Partnership With MorphoSys To Enable MorphoSys' Acquisition Of Constellation; Royalty To Acquire Rights To Receive Royalties On Multiple Products   Benzinga
May 20, 2021
08:30AM EDT  Bio-Rad to Participate at Jefferies Virtual Healthcare Conference   Business Wire
May 13, 2021
01:41PM EDT  5 Value Stocks In The Healthcare Sector   Benzinga
Apr 29, 2021
05:06PM EDT  Bio-Rad Laboratories Q1 EPS $5.21 Beats $3.00 Estimate, Sales $726.80M Beat $660.98M Estimate   Benzinga
04:15PM EDT  Bio-Rad Reports First-Quarter 2021 Financial Results   Business Wire
08:15AM EDT  The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx   Benzinga
04:10AM EDT  Earnings Scheduled For April 29, 2021   Benzinga
Apr 28, 2021
11:05AM EDT  A Preview Of Bio-Rad Laboratories's Earnings   Benzinga
Apr 24, 2021
09:24AM EDT  The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx   Benzinga
Apr 15, 2021
08:30AM EDT  Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021   Business Wire
Apr 5, 2021
10:07AM EDT  5 Value Stocks In The Healthcare Sector   Benzinga
Mar 5, 2021
04:16PM EST  Bio-Rad to Participate in Barclays Global Healthcare Conference 2021   Business Wire
Feb 23, 2021
07:40AM EST  Biolase Appoints John R. Beaver As President And CEO   Benzinga
Feb 22, 2021
04:15PM EST  Bio-Rad to Participate in Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference   Business Wire
Feb 16, 2021
06:31AM EST  Biodesix To Provide Antigen And Droplet Digital PCR Testing For Chicago Public School Teachers And Staff   Benzinga
Feb 15, 2021
10:44AM EST  A Look Into Healthcare Sector Value Stocks   Benzinga
Feb 12, 2021
09:49AM EST  Citigroup Maintains Buy on Bio-Rad Laboratories, Raises Price Target to $750   Benzinga
Feb 11, 2021
04:52PM EST  Bio-Rad Laboratories: Q4 Earnings Insights   Benzinga
04:21PM EST  Bio-Rad Sees FY21 Adj. Currency-Neutral Sales Growth 4.5-5% Year Over Year   Benzinga
04:20PM EST  Bio-Rad Laboratories Q4 Adj. EPS $4.01 Beats $3.29 Estimate, Sales $757.90M Beat $686.80M Estimate   Benzinga
04:20PM EST  Bio-Rad Reports Fourth-Quarter and Full-Year 2020 Financial Results   Business Wire
03:51AM EST  Earnings Scheduled For February 11, 2021   Benzinga
Feb 10, 2021
10:31AM EST  Earnings Preview: Bio-Rad Laboratories   Benzinga
Feb 8, 2021
09:51AM EST  A Look Into Healthcare Sector Value Stocks   Benzinga
Feb 5, 2021
12:39PM EST  Jefferies Maintains Buy on Bio-Rad Laboratories, Raises Price Target to $725   Benzinga
Feb 4, 2021
06:19AM EST  Bio-Rad Laboratories Says Initiated Restructuring Plan; Estimates It will Incur $125M-$130M In Total Costs   Benzinga
06:16AM EST  Bio-Rad Laboratories Plans Restructuring That Will Eliminate Total Of 530 Positions   RTTNews
Jan 25, 2021
04:15PM EST  Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021   Business Wire
Jan 21, 2021
08:13AM EST  Intra-Cellular Therapies Highlights CAPLYTA Open-Label Safety Switching Study In Patients With Schizophrenia Published In Journal, Schizophrenia Research   Benzinga
Jan 8, 2021
08:30AM EST  Bio-Rad to Participate in Fireside Chat at the 39th Annual J.P. Morgan Healthcare Conference on January 11   Business Wire
Dec 21, 2020
09:54AM EST  A Look Into Healthcare Sector Value Stocks   Benzinga
Dec 17, 2020
05:26PM EST  12 Emerging Technologies To Watch In 2021   Benzinga
Dec 11, 2020
08:11AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street   Benzinga
Dec 10, 2020
05:33PM EST  Bio-Rad Provides Outlook Through 2023   Business Wire
Nov 23, 2020
10:24AM EST  5 Value Stocks To Watch In The Healthcare Sector   Benzinga
Nov 10, 2020
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 6, 2020
07:47AM EST  The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold   Benzinga
Nov 5, 2020
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
Nov 4, 2020
08:21AM EST  The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings   Benzinga
Nov 3, 2020
07:38AM EST  The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure   Benzinga
Nov 2, 2020
09:10AM EST  Stocks Trading Near 52-Week Highs Before Open On Monday, Nov. 2, 2020: BIO, CLGX, EIGI, DNKN, PSHG, MDLY, NIO   Benzinga
Oct 29, 2020
05:06PM EDT  Bio-Rad Sees FY 2020 Sales Up 5.9%-6.3%   Benzinga
05:05PM EDT  Bio-Rad Laboratories Q3 EPS $3.00 Beats $1.80 Estimate, Sales $647.26M Beat $570.58M Estimate   Benzinga
04:59PM EDT  Bio-Rad Laboratories: Q3 Earnings Insights   Benzinga
04:16PM EDT  Bio-Rad Reports Third-Quarter 2020 Financial Results   Business Wire
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
04:08AM EDT  Earnings Scheduled For October 29, 2020   Benzinga
Oct 25, 2020
02:29PM EDT  IPO Outlook: Insurance Cos., Mortgage Providers, Leslie's Pool Supplies Highlight This Week's Offerings   Benzinga
Oct 22, 2020
07:52AM EDT  The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat   Benzinga
Oct 21, 2020
08:04AM EDT  The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings   Benzinga
Oct 20, 2020
08:17AM EDT  The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger   Benzinga
Oct 19, 2020
08:30AM EDT  Bio-Rad to Report Third-Quarter 2020 Financial Results, Thursday, October 29, 2020   Business Wire
Sep 21, 2020
09:56AM EDT  A Look Into Healthcare Sector Value Stocks   Benzinga
Aug 19, 2020
07:08AM EDT  Pluristem Announces End Of Patient Enrollment In Phase I Hematology Study   Benzinga
Aug 12, 2020
07:14AM EDT  Biorad Partner, Biodesix, Reports Plans To Provide Coronavirus ddPCR Diagnostic Testing For Colorado State University, No Terms Disclosed   Benzinga
07:11AM EDT  Biodesix Plans To Provide Coronavirus ddPCR Diagnostic Testing For Colorado State University, No Terms Disclosed   Benzinga
Aug 4, 2020
08:35AM EDT  U.S. Court Of Appeals For Federal Circuit Affirms 10x Genomics Willfully Infringed Bio-Rad U.S. Patent   RTTNews
08:32AM EDT  Bio-Rad Labs Reports US Appeals Court Affirms 10x Genomics Willfully Infringed Bio-Rad Patent, Upholds Lower Courts Award Of Damages For $23.9M   Benzinga
08:30AM EDT  The United States Court of Appeals for the Federal Circuit Affirms That 10x Genomics Willfully Infringed Bio-Rad U.S. Patent and Upholds Lower Court's Award of Damages   Business Wire
Jul 31, 2020
08:18AM EDT  10 Biggest Price Target Changes For Friday   Benzinga
07:10AM EDT  Citigroup Maintains Buy on Bio-Rad Laboratories, Raises Price Target to $625   Benzinga
Jul 30, 2020
04:57PM EDT  Bio-Rad Laboratories Q2 EPS $1.61 Beats $1.15 Estimate, Sales $536.90M Beat $503.82M Estimate   Benzinga
04:15PM EDT  Bio-Rad Reports Second-Quarter 2020 Financial Results   Business Wire
04:06AM EDT  Earnings Scheduled For July 30, 2020   Benzinga
Jul 15, 2020
08:01PM EDT  Bio-Rad to Report Second-Quarter 2020 Financial Results, Thursday, July 30, 2020   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC